{"id":"south-australian-public-health-notifiable-and-controlled-notifiable-conditions-regulations-2025","name":"South Australian Public Health (Notifiable and Controlled Notifiable Conditions) Regulations 2025","slug":"south-australian-public-health-notifiable-and-controlled-notifiable-conditions-regulations-2025","collection":"regulation","jurisdiction":"sa","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":237336,"registerId":"sa-south-australian-public-health-notifiable-and-controlled-notifiable-conditions-regulations-2025-current","compilationNumber":null,"startDate":"2026-04-06","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"South Australian Public Health (Notifiable and Controlled Notifiable Conditions) Regulations 2025","content":"South Australia\nSouth Australian Public Health (Notifiable and Controlled Notifiable Conditions) Regulations 2025\nunder the South Australian Public Health Act 2011\n\nContents\n1\tShort title\n2\tCommencement\n3\tInterpretation\n4\tNotifiable conditions\n5\tControlled notifiable conditions\n6\tPrescribed classes of persons (section 64(1)(c) of Act)\n7\tExemption from notification requirements\n8\tCorresponding law\nSchedule 1—Repeal of South Australian Public Health (Notifiable and Controlled Notifiable Conditions) Regulations 2012\nLegislative history\n\n1—Short title\nThese regulations may be cited as the South Australian Public Health (Notifiable and Controlled Notifiable Conditions) Regulations 2025.\n2—Commencement\nThese regulations come into operation on the day on which they are made.\n3—Interpretation\nIn these regulations—\nAct means the South Australian Public Health Act 2011;\nadverse event following immunisation or AEFI means any untoward medical occurrence that follows immunisation (whether or not the occurrence has a causal relationship with the vaccine);\nAustralian Immunisation Handbook means The Australian Immunisation Handbook published by the Commonwealth Department of Health (as in force from time to time);\nAustralian Register of Therapeutic Goods means the register maintained under section 9A of the Therapeutic Goods Act 1989 of the Commonwealth;\nnotifiable adverse event following immunisation or notifiable AEFI means an AEFI that is not a very common or common AEFI;\npoint‑of‑care test means a test included on the Australian Register of Therapeutic Goods that is performed on a person by a medical practitioner, or a person on behalf of a medical practitioner, at the time of the person's consultation (however described) with the medical practitioner;\nvery common or common adverse event following immunisation or very common or common AEFI means an AEFI that is listed as a very common or common adverse event in the Australian Immunisation Handbook or in clinical advice relating to adverse events published by the Australian Technical Advisory Group on Immunisation (ATAGI) established by the Commonwealth Government.\n4—Notifiable conditions\nFor the purposes of section 63 of the Act, the following diseases or medical conditions are declared to be notifiable conditions:\nAcute post-streptococcal glomerulonephritis\nAnthrax\nArbovirus infection (not otherwise listed)\nBarmah Forest virus infection\nBotulism\nBrucellosis\nCampylobacter infection\nCandida auris\nCarbapenemase-producing Enterobacterales (CPE)\nChancroid\nChikungunya virus infection\nChlamydia trachomatis\nCholera\nCoronavirus disease 2019 (COVID-19)\nCreutzfeldt-Jakob disease\nCryptosporidiosis\nDengue virus infection\nDiphtheria\nDonovanosis\nFood poisoning\nGonococcal infection\nHaemolytic‑uraemic syndrome (HUS)\nHaemophilus influenzae infection (invasive)\nHendra virus infection\nHepatitis A\nHepatitis B\nHepatitis C\nHepatitis D\nHepatitis E\nHuman immunodeficiency virus infection (HIV)\nInfluenza\nInfluenza (avian in humans)\nInfluenza (pandemic)\nInvasive group A streptococcal disease\nJapanese encephalitis virus infection\nLegionellosis\nLeprosy\nLeptospirosis\nListeriosis\nLyssavirus infection (including rabies, Australian bat lyssavirus and other lyssavirus infections)\nMalaria\nMeasles\nMeningococcal disease\nMiddle East respiratory syndrome coronavirus infection (MERS‑CoV)\nMonkeypox virus infection (mpox)\nMumps\nMurray Valley encephalitis virus infection\nMycobacterial infection (non‑tuberculous)\nNotifiable adverse event following immunisation\nParatyphoid (Salmonella Paratyphi infection)\nPertussis\nPlague\nPneumococcal disease (invasive)\nPoliovirus infection\nPrion disease (not otherwise listed)\nPsittacosis / Ornithosis\nQ Fever\nRespiratory syncytial virus (RSV)\nRheumatic fever\nRheumatic heart disease\nRoss River virus infection\nRotavirus\nRubella and congenital rubella syndrome\nSalmonella infection\nSevere acute respiratory syndrome (SARS)\nSevere acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2)\nShiga toxin producing Escherichia coli infection (STEC)\nShigella infection\nSmallpox\nSyphilis and congenital syphilis\nTetanus\nTuberculosis\nTularaemia\nTyphoid (Salmonella Typhi infection)\nVaricella‑zoster virus infection\nVibrio parahaemolyticus infection\nViral haemorrhagic fever\nWest Nile virus infection (including Kunjin variant)\nYellow fever\nYersiniosis.\n5—Controlled notifiable conditions\nFor the purposes of section 70 of the Act, the following diseases or medical conditions are declared to be controlled notifiable conditions:\nCholera\nCoronavirus disease 2019 (COVID-19)\nDiphtheria\nHepatitis A\nHepatitis B\nHepatitis C\nHepatitis D\nHepatitis E\nHuman immunodeficiency virus infection (HIV)\nInfluenza (avian in humans)\nInfluenza (pandemic)\nMeasles\nMiddle East respiratory syndrome coronavirus infection (MERS‑CoV)\nPlague\nPoliovirus infection\nSalmonella infection\nSevere acute respiratory syndrome (SARS)\nSevere acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2)\nShigella infection\nSmallpox\nSyphilis\nTuberculosis\nViral haemorrhagic fever\nYellow fever.\n6—Prescribed classes of persons (section 64(1)(c) of Act)\n\t(1)\tFor the purposes of section 64(1)(c) of the Act, each of the following is a person of a prescribed class, but only in respect of a suspicion that a person is suffering, or has died from, a notifiable AEFI:\n\t(a)\ta registered health practitioner who is authorised under regulation 18(3) of the Controlled Substances (Poisons) Regulations 2011 to administer a prescription drug (not being a drug of dependence) to a person as part of an immunisation program referred to in that regulation;\n\t(b)\ta pharmacist who is authorised under regulation 18(3a) of the Controlled Substances (Poisons) Regulations 2011 to administer a drug that is a vaccine to a person.\n\t(2)\tA person of a class prescribed under subregulation (1) who suspects that a person is suffering from a notifiable AEFI is not required to make a report under section 64(1) of the Act with respect to that case if the practitioner knows or reasonably believes that a report of the case has already been made to the Chief Public Health Officer by a medical practitioner or another person of a class prescribed under subregulation (1).\n\t(3)\tFor the purposes of section 64(10)(c) of the Act—\n\t(a)\tthe responsible person for a registered health practitioner of a class prescribed under subregulation (1)(a) is the registered health practitioner; and\n\t(b)\tthe responsible person for a pharmacist of a class prescribed under subregulation (1)(b) is the pharmacist.\n7—Exemption from notification requirements\n\t(1)\tPursuant to section 109(2)(t) of the Act, a medical practitioner is exempt from the application of section 64(1) of the Act—\n\t(a)\tin respect of a suspicion (other than a suspicion formed on the basis of a point‑of‑care test) that a person has a designated notifiable condition; or\n\t(b)\tin respect of a suspicion formed on the basis of a point‑of‑care test that a person has a designated notifiable condition if the medical practitioner knows or reasonably believes that a report has already been made to the Chief Public Health Officer by a pathology service; or\n\t(c)\tin respect of a suspicion that a person is suffering from a notifiable AEFI if the medical practitioner knows or reasonably believes that a report has already been made to the Chief Public Health Officer by another medical practitioner or a person of a class prescribed under regulation 6(1).\n\t(2)\tIn this regulation—\ndesignated notifiable condition means—\n\t(a)\tChlamydia trachomatis, but only in relation to a person who is of or over the age of 17 years; or\n\t(b)\tCoronavirus disease 2019 (COVID‑19); or\n\t(c)\tInfluenza; or\n\t(d)\tRespiratory syncytial virus (RSV); or\n\t(e)\tRotavirus; or\n\t(f)\tSevere acute respiratory syndrome coronavirus infection (SARS‑CoV‑2); or\n\t(g)\tVaricella‑zoster virus infection.\n8—Corresponding law\nFor the purpose of the definition of corresponding law in section 83(1) of the Act, the following are declared to be corresponding laws:\nHealth Act 1911 of Western Australia;\nNotifiable Diseases Act 1981 of the Northern Territory;\nPublic Health Act 1997 of the Australian Capital Territory;\nPublic Health Act 2010 of New South Wales;\nPublic Health Act 2005 of Queensland;\nPublic Health Act 1997 of Tasmania;\nPublic Health and Wellbeing Act 2008 of Victoria.\nSchedule 1—Repeal of South Australian Public Health (Notifiable and Controlled Notifiable Conditions) Regulations 2012\nThe South Australian Public Health (Notifiable and Controlled Notifiable Conditions) Regulations 2012 are repealed.\nLegislative history\nNotes\n\t•\tFor further information relating to the Act and subordinate legislation made under the Act see the Index of South Australian Statutes or www.legislation.sa.gov.au.\nPrincipal regulations\nYear\nNo\nReference\nCommencement\n2025\n48\nGazette 26.6.2025 p2099 \n26.6.2025: r 2\n","sortOrder":0}],"analysis":{"summary":{"complexity_score":2,"scope_assessment":{"changed":false,"description":"Insufficient information to assess whether the scope changed from original intent. The document content was inaccessible. Based on the title, these regulations appear to be a standard instrument updating the list of notifiable and controlled notifiable conditions under South Australian public health law, which is a routine and expected regulatory function."},"complexity_factors":["No actual legislative text was retrievable — the source URL returned a 404/Page Not Found error","Complexity cannot be properly assessed without the document content","Score of 2 reflects only the inherent moderate complexity typical of public health notification regulations, based on the title alone","Notifiable conditions regulations typically involve schedules of diseases, defined obligations on reporters, and tiered response frameworks — all of which add complexity that cannot be confirmed here"],"plain_english_summary":"This regulation would set which diseases and health events South Australian clinicians, laboratories and others must notify to public health authorities, and designate a subset as \"controlled\" conditions that allow stronger interventions (testing, treatment, isolation). \n\nIt primarily affects healthcare workers, pathology services, diagnosed individuals and SA Health, because it determines reporting duties, the scope of public health powers, and how outbreaks are managed."},"flash_summary_failed":{"failed":true,"reason":"Unauthenticated. Configure AI_GATEWAY_API_KEY or use a provider module. Learn more: https://ai-sdk.dev/unauthenticated-ai-gateway","source":"analysis-cron"},"flash_summary":{"complexity_score":3,"scope_assessment":{"changed":true,"description":"This instrument expressly repeals the 2012 regulations and substitutes an updated schedule of notifiable and controlled notifiable conditions and altered reporting rules, including new definitions and specified reporter classes and exemptions. That replacement updates the universe of reportable conditions and who is required or exempted from reporting."},"complexity_factors":["Long enumerated lists of notifiable and controlled notifiable conditions increase maintenance and cross-referencing (regs 4–5).","Multiple defined technical terms that link to external instruments (Australian Immunisation Handbook, ARTG, ATAGI) create dependence on external material (reg 3).","Prescribed reporter classes and limited exemptions require judgment about when reporting is redundant or required, creating operational complexity for clinicians (regs 6–7).","Cross‑references to other South Australian and Commonwealth instruments and to the principal Act add legal layering (Act; reg 8 declaring corresponding laws).","Repeal and replacement of the 2012 regulations imposes transitional and implementation tasks for administrators (Schedule 1)."],"plain_english_summary":"These regulations update South Australia’s disease‑reporting framework by naming which diseases are 'notifiable' and which are 'controlled notifiable', defining key terms (including notifiable adverse events following immunisation) and specifying who must report suspected cases. They replace the 2012 regulations.\n\nThey affect medical practitioners, pharmacists, registered health practitioners, pathology services and the Chief Public Health Officer by creating duties and limited exemptions for reporting; clinicians bear the administrative and time costs, while public health authorities receive information for surveillance and response."},"issue_detection":{"absurdities":[],"contradictions":[]},"kimi_summary":{"content_quality":"ok","complexity_score":4,"scope_assessment":{"changed":false,"description":"The legislation maintains the same core scope as its 2012 predecessor—establishing disease notification requirements under the Public Health Act 2011. While it adds new specific conditions (Candida auris, mpox, RSV) and refines reporting mechanisms for vaccine adverse events and point-of-care testing, these represent updates within the existing public health surveillance framework rather than expansion beyond the original purpose."},"complexity_factors":["Multiple defined terms in interpretation section (7 definitions including nested definitions for AEFI categories)","Cross-references to other legislation (Controlled Substances (Poisons) Regulations 2011, Therapeutic Goods Act 1989, Australian Immunisation Handbook)","Conditional logic in reporting exemptions (Regulation 7) with multiple nested conditions based on test type, disease type, and prior reporting status","Dual classification system requiring understanding of distinction between 'notifiable' and 'controlled notifiable' conditions","Specific age-based carve-out for chlamydia reporting (over 17 years only)","Responsible person provisions linking back to practitioner classes with specific attribution rules"],"plain_english_summary":"This legislation is a set of rules made under South Australia's main public health law. It creates two lists of diseases that doctors and other health workers must report to the government.\n\n**What it does:**\n\n*   **Notifiable conditions** (Regulation 4): A long list of diseases (from anthrax to yellow fever, including COVID-19, measles, HIV, and food poisoning) that health professionals must report to the Chief Public Health Officer. This helps the government track disease outbreaks and respond quickly.\n*   **Controlled notifiable conditions** (Regulation 5): A shorter, more serious list of diseases (including cholera, diphtheria, plague, and smallpox) where the government has extra powers to control the spread, such as ordering isolation or quarantine.\n*   **Who must report:** Mostly doctors, but now also specifically includes authorised nurses and pharmacists who give vaccines, but only for reporting bad reactions to vaccines (called \"notifiable adverse events following immunisation\" or AEFI).\n*   **Exemptions:** Doctors don't have to report certain common infections (like chlamydia in adults over 17, flu, COVID-19, RSV, and chickenpox) if they suspect them based on symptoms alone—unless the diagnosis comes from a rapid point-of-care test and no one else has reported it yet. This avoids duplicate reporting when pathology labs already notify the government.\n*   **Vaccine safety:** Introduces specific rules for reporting serious bad reactions to vaccines, distinguishing between common side effects (which don't need reporting) and rarer, more serious ones (which do).\n\n**Why it matters:**\nThese rules are essential for disease surveillance. They ensure South Australia can detect outbreaks early, monitor vaccine safety, and trigger public health responses for dangerous diseases. The 2025 version updates the 2012 rules, adding new conditions like Candida auris, mpox, and RSV, and refining who reports what to reduce administrative burden on doctors for common illnesses."}},"importantCases":[],"_links":{"self":"/api/acts/south-australian-public-health-notifiable-and-controlled-notifiable-conditions-regulations-2025","history":"/api/acts/south-australian-public-health-notifiable-and-controlled-notifiable-conditions-regulations-2025/history","analysis":"/api/acts/south-australian-public-health-notifiable-and-controlled-notifiable-conditions-regulations-2025/analysis","conflicts":"/api/acts/south-australian-public-health-notifiable-and-controlled-notifiable-conditions-regulations-2025/conflicts","importantCases":"/api/acts/south-australian-public-health-notifiable-and-controlled-notifiable-conditions-regulations-2025/important-cases","documents":"/api/acts/south-australian-public-health-notifiable-and-controlled-notifiable-conditions-regulations-2025/documents"}}